We serve Chemical Name:nitrilotriacetic acid CAS:139-13-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:nitrilotriacetic acid
CAS.NO:139-13-9
Synonyms:nitrilotriacetate;combretastatin A2;1710776;aminotriacetic acid;Prochlorperazin;MFCD00004287;N,N-Bis(carboxymethyl)glycine,NTA,Tris(carboxymethyl)amine;2,2′,2”-Nitrilotriacetic acid;tri(carboxymethyl)amine;Triglycine;Nitrilotriessigsaeure;EINECS 205-355-7;Glycine, N,N-bis(carboxymethyl)-;nitriloacetate;N,N-bis(carboxymethoxy)glycine;nitrilotriacetic acid;Triglycollamic acid;4-04-00-02441;prochlorperazine Maleate;Tris(carboxymethyl)amine;α,α’,α”-Trimethylaminetricarboxylic acid;Ntana3;Prochlorperazinemaleat;UNII-KA90006V9D;N,N-Bis(carb;a,a’,a”-Trimethylaminetricarboxylic Acid;NTA;Complexon I
Molecular Formula:C6H9NO6
Molecular Weight:191.139
HS Code:29224995
Physical and Chemical Properties:
Melting point:245 °C (dec.)(lit.)
Boiling point:498.2±40.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.558
PSA:115.14000
Exact Mass:191.042984
LogP:-1.76
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:2811
Packing Group:II
Contact us for information like nitrilotriacetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Complexon I physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,nitrilotriacetate Use and application,Nitrilotriessigsaeure technical grade,usp/ep/jp grade.
Related News: A CDMO must have bolt-on capabilities with efficient chemistry which translates into adding new capabilities that the specific molecule development may require quickly. 3-(6-chloro-3-pyridyl)methyl-2-iminothiazolidine fumarate manufacturers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, 2H-Pyran, 2-(3,13-eicosadiynyloxy)tetrahydro- suppliers At least five million people worldwide have a form of lupus. No new treatments have been approved for SLE in over 10 years. 1-(2-(furan-2-yl)phenyl)ethan-1-one vendor & factory.
